Paul R. Hansen - Jan 18, 2022 Form 4 Insider Report for Vyant Bio, Inc. (VYNT)

Role: Director
Signature: /s/ Andrew LaFrence, attorney-in-fact
Stock symbol: VYNT
Transactions as of: Jan 18, 2022
Transactions value $: $3,749
Form type: 4
Date filed: 1/20/2022, 08:19 PM
Previous filing: Feb 27, 2023
Next filing: Apr 1, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYNT	Common Stock, $0.0001 par value	Award	$3.75K	+2.86K	+0.42%	$1.31	686K	Jan 18, 2022	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 18, 2022, the Reporting Person was granted 2,862 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2023, so long as Reporting Person remains a director though that date.
F2	Includes 64,901 shares previously held by a trust account which were transferred to the Reporting Person and are now held directly.